| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |